Business Context and Reporting Period
Company: Tower Semiconductor Ltd.
Filing Type: Form 20-F (Annual Report)
Reporting Period: Fiscal year ended December 31, 2004
Business Overview: Tower is an independent wafer foundry based in Israel, specializing in CMOS image sensors, embedded flash, mixed-signal, and RF CMOS technologies. The company operates two facilities: Fab 1 (150-mm wafers, 1.0 to 0.35-micron) and Fab 2 (200-mm wafers, 0.18-micron and below). Fab 2 is in a critical ramp-up phase, with production capacity at 14,600 wafers per month as of year-end 2004.
Key Financial Metrics (Year Ended Dec 31, 2004)
| Metric | 2004 (in thousands) | 2003 (in thousands) |
|---|---|---|
| Sales | $126,055 | $61,368 |
| Cost of Sales | $228,410 | $122,395 |
| Gross Loss | $(102,355) | $(61,027) |
| Operating Loss | $(140,705) | $(104,351) |
| Net Loss | $(137,768) | $(114,261) |
| Basic Loss Per Share | $(2.13) | $(2.40) |
| Cash and Cash Equivalents | $81,457 | $56,490 |
| Long-Term Debt | $497,000 | $431,000 |
| Shareholders' Equity | $167,980 | $229,457 |
Note: Financial statements are prepared in accordance with Israeli GAAP. Reconciliation to U.S. GAAP is provided in Note 19 of the filing.
Material Changes vs. Prior Period
- Revenue Growth: Sales increased 105.4% to $126.1 million, driven by the ramp-up of Fab 2 capacity and increased production levels.
- Widening Losses: Despite revenue growth, the net loss increased to $137.8 million (from $114.3 million in 2003). This was primarily due to a $41.4 million increase in gross loss and a $19.9 million increase in financing expenses.
- Depreciation Impact: Depreciation and amortization expenses surged to $121.1 million (from $54.6 million in 2003) as Fab 2 assets were fully depreciated for the year following their commencement of operations in late 2003.
- Financing Costs: Net financing expenses rose to $29.7 million due to increased loan balances for Fab 2, the discontinuation of interest capitalization, and higher interest rates (LIBOR + 2.5%).
- One-Time Gain: Other income included a $32.4 million net capital gain from the sale of the company's entire equity stake in Saifun Semiconductors Ltd.
Guidance, Outlook, Risks, and Contingencies
Liquidity and Financing Risks
The company faces significant liquidity risks. In May 2005, Tower signed a Letter of Intent (LOI) with its banks for up to $30 million in financing, contingent on raising a similar amount from investors. As of the filing date, investors had indicated willingness to invest $23.5 million. Management stated that without this funding or alternative financing, the company may not have adequate liquidity for the second half of 2005 and could be forced to cease operations.
Covenant Compliance
The company estimated it may not comply with certain financial ratios and covenants under its credit facility for the third quarter of 2005 and thereafter. While a waiver was obtained for Q4 2004, failure to secure a definitive amendment to the credit facility could result in the acceleration of debt repayment.
Government Grants
Tower relies on Israeli Investment Center grants (up to $250 million total). The company does not expect to meet the original investment completion deadline of December 31, 2005. Failure to secure an extension or new expansion plan could result in the cancellation of grants and a requirement to repay funds already received ($150.6 million as of year-end 2004).
Operational Risks
- Fab 2 Ramp-Up: Completion of equipment installation and technology transfer (specifically 0.13-micron) is critical. Delays or cost overruns could materially adversely affect the business.
- Customer Concentration: Five significant customers accounted for approximately 63% of 2004 revenues.
- Industry Cyclicality: The semiconductor industry is highly cyclical, with risks of overcapacity and downward price pressure.
Investor Verification Checklist
- Financing Execution: Verify if the definitive amendment to the credit facility and the $30 million investor funding (LOI) were successfully closed to ensure short-term solvency.
- Grant Extension: Confirm the status of negotiations with the Israeli Investment Center regarding the extension of the Fab 2 investment period beyond December 31, 2005.
- Covenant Compliance: Monitor Q3 and Q4 2005 financial results to ensure compliance with revised bank covenants to avoid debt acceleration.
- Fab 2 Utilization: Assess actual production capacity utilization and revenue generation from Fab 2 to determine if the facility can achieve the high utilization rates required for profitability.
- Customer Orders: Verify the status of orders from the top five customers, particularly regarding the ramp-up of new technologies (0.13-micron) in Fab 2.